NEWSWORTHY
Todai-linked venture developing technology for speedy home flu test
Every winter, people running a fever and complaining of muscle pain swarm the nation's clinics, suspecting one thing: the flu. An estimated 12 million to 16 million people in Japan come down with the flu every year. When flu season is in full swing, it ...
Nagoya venture taps researcher's reagent to make quick work of synthesizing proteins
A Nagoya-based venture has started selling a reagent that allows researchers to significantly reduce the time needed to synthesize proteins, supporting the development of medicines including one that can control the growth of cancer cells. The reagent sold by NUProtein Co., which originated from Nagoya ...
U.S. venture firm aims to break corporate hold on Japanese startups
When he worked in Silicon Valley, venture investor James Riney was used to aggressive entrepreneurs who pitched him for financing any time they got a two-minute opening. Now that he's in Tokyo, the culture is so different he's changed his ways. Startup founders are ...
No-sweat risk-taker Arora lets ¥60 billion ride on SoftBank's future
It's a fall evening in Tokyo, and Nikesh Arora is supposed to be in two places at once. This is a common dilemma for the 47-year-old president of SoftBank Group Corp., who splits his time between Silicon Valley, Japan and India. Arora is scheduled for ...
Quantum wins $20.5 million funding to build a rapid DNA sequencer
Quantum Biosystems Inc., an Osaka-based company developing a faster genome sequencer, has raised ¥2.4 billion in venture-capital funding from firms including Jafco Co., people with knowledge of the matter said. The investors also include state-backed Innovation Network Corp. of Japan, Mizuho Capital Co., University of ...
